FindTrial
Sign In

Single-site robotic-assisted radical prostatectomy (RARP) versus multi-site RARP in the treatment of rostate cancer: a multicenter retrospective clinical trial

Single-site robotic-assisted radical prostatectomy (RARP) versus multi-site RARP in the treatment of rostate cancer: a multicenter retrospective clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090731
Enrollment
Unknown
Registered
2024-10-12
Start date
2024-10-20
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Interventions

Single-site robot-assisted radical prostatectomy group:None
Multi-sites robot-assisted radical prostatectomy group:None

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Male patients undergoing robotic-assisted radical prostatectomy for prostate cancer at each study centre between 2021.1-2024.1.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Continence recovery rate at 3 months postoperatively;Potency recovery rate at 3 months postoperatively;—

Secondary

MeasureTime frame
Continence recovery rate at 1 month postoperatively;Continence recovery rate at 6 months postoperatively;Potency recovery rate at 6 months postoperatively;Continence recovery rate at 12 months postoperatively;Potency recovery rate at 12 months postoperatively;—

Countries

China

Contacts

Public ContactRen Shancheng

Shanghai Changzheng Hospital

renshancheng@gmail.com+86 139 1779 3885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026